Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. For as long as I’ve worked in data and analytics, predictions of disappearing roles have ...

IMNN-001 program is currently advancing its OVATION 3 pivotal Phase 3 trial per plan LAWRENCEVILLE, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc. (Nasdaq: IMNN) , a clinical-stage company in ...

SEATTLE – Oct. 7, 2025 – Beyond the Hype: A Benchmark Study of AI in the SOC, a new report from the Cloud Security Alliance (CSA), the world’s leading not-for-profit organization committed to AI, ...

COLUMBUS, Ohio — Ohio’s growing data center industry is reshaping the state’s economy, supporting thousands of jobs and billions in economic activity, according to a new study released Thursday by the ...

Nine possible 2026 Kentucky Derby (G1) contenders will square off in Saturday’s $500,000 Champagne (G1) at Aqueduct. Held at a distance of one mile (longer than many of the entrants have attempted ...

Abstract: Guidance for checklists and collection of data required for performing an arc-flash hazard calculation study, in accordance with the process defined in IEEE ...

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...

Rather than spending their time executing manual queries, data analysts will increasingly operate like AI engineers—reviewing, refining, and validating AI-generated outputs. AI is not only reshaping ...

Artificial intelligence-native data insights startup Wisdom AI Inc. is expanding its platform today with the launch of Proactive Agents. The agents act like automated data analysts and work around the ...

(RTTNews) - Viking Therapeutics, Inc. (VKTX), a clinical-stage biopharmaceutical company, Tuesday announced positive top-line results from its Phase 2 VENTURE study of the oral tablet formulation of ...